Search for other papers by Marina Weber Pasa in
Google Scholar
PubMed
Search for other papers by Rafael Selbach Scheffel in
Google Scholar
PubMed
Search for other papers by André Borsatto Zanella in
Google Scholar
PubMed
Search for other papers by Ana Luiza Maia in
Google Scholar
PubMed
Search for other papers by José Miguel Dora in
Google Scholar
PubMed
highest dose) and LT 3 to 40 μg/day to achieve a euthyroid state during hospitalization. Thyroid ultrasound displayed a topical and homogeneous gland, with regular contours and increased age-related size (total volume of 2.4 mL, RV 0.2–2.7). Thyroid
Search for other papers by Bharath Bachimanchi in
Google Scholar
PubMed
Search for other papers by Suresh Vaikkakara in
Google Scholar
PubMed
Search for other papers by Alok Sachan in
Google Scholar
PubMed
Search for other papers by Ganji Praveen Kumar in
Google Scholar
PubMed
Search for other papers by Ashok Venkatanarasu in
Google Scholar
PubMed
Search for other papers by Palaparti Sai Krishna Chaitanya in
Google Scholar
PubMed
Search for other papers by Bekkem Sreedivya in
Google Scholar
PubMed
Search for other papers by Ravi Poojari in
Google Scholar
PubMed
hormones that were assessed and the methods used are given in Table 1 . The patients were then started on T 4 replacement in doses titrated to achieve a normal TSH of 0.5–5 mIU/L. Two months or more after achieving euthyroid status (reconfirmed by TSH
Search for other papers by Bjarke Borregaard Medici in
Google Scholar
PubMed
Search for other papers by Jeppe Lerche la Cour in
Google Scholar
PubMed
Search for other papers by Luba Freja Michaelsson in
Google Scholar
PubMed
Search for other papers by Jens Oscar Faber in
Google Scholar
PubMed
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
symptoms despite being biochemically euthyroid [ 1 ]. European Thyroid Association (ETA) guidelines [ 2 ] from 2012 suggest that L-T 4 /liothyronine (L-T 3 ) combination therapy could be considered as an experimental approach for compliant patients with
Search for other papers by Earn H. Gan in
Google Scholar
PubMed
Search for other papers by Anna L. Mitchell in
Google Scholar
PubMed
Search for other papers by Ruth Plummer in
Google Scholar
PubMed
Search for other papers by Simon Pearce in
Google Scholar
PubMed
Search for other papers by Petros Perros in
Google Scholar
PubMed
biochemically euthyroid, 8 weeks following antithyroid drug treatment. The block and replace therapy for Graves disease was withdrawn after 12 months. He continues to receive 6-monthly tremelimumab treatment to date and has remained biochemically and clinically
Search for other papers by Roberto Negro in
Google Scholar
PubMed
Search for other papers by Giacomo Greco in
Google Scholar
PubMed
oxidative stress is higher in overt hypothyroid patients than in euthyroid or subclinical hypothyroid patients, and the total antioxidant status is lower in overt hypothyroid subjects compared to the other groups [ 15 ]. Selenium (Se) has physiological
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Marko Stojanović in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Sandra Pekić in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Mirjana Doknić in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Dragana Miljić in
Google Scholar
PubMed
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Slavica Ćirić in
Google Scholar
PubMed
Endocrine Surgery Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Aleksandar Diklić in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Svetislav Tatić in
Google Scholar
PubMed
Search for other papers by Miloje Joksimović in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Emilija Manojlović-Gačić in
Google Scholar
PubMed
Institute of Pathology, Clinical Center of Serbia, Belgrade, Serbia
Search for other papers by Milica Skender-Gazibara in
Google Scholar
PubMed
Neuroendocrine Department, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Clinic for Endocrinology, Diabetes and Metabolic Diseases, Clinical Center of Serbia
Search for other papers by Vera Popović in
Google Scholar
PubMed
local lymphadenopathy, was found. Physical examination was otherwise unremarkable. The patient had a long-standing euthyroid multinodular goiter since the age of 20. She reported no compressive symptoms and no past ultrasound (US) reports were available
Search for other papers by Federica D’Aurizio in
Google Scholar
PubMed
Search for other papers by Alessia Biasotto in
Google Scholar
PubMed
Search for other papers by Claudia Cipri in
Google Scholar
PubMed
Search for other papers by Franco Grimaldi in
Google Scholar
PubMed
Search for other papers by Jessica Zucco in
Google Scholar
PubMed
Search for other papers by Stefania Marzinotto in
Google Scholar
PubMed
Department of Medicine, University of Udine, Udine, Italy
Search for other papers by Francesco Curcio in
Google Scholar
PubMed
Search for other papers by Salvatore Benvenga in
Google Scholar
PubMed
with both TSH and the clinical status since she continued to be clinically euthyroid. On the same serum sample, thyroid autoantibodies were negative (TPOAb = 52 U/mL; thyroglobulin antibodies, TgAb = 17 U/mL, cut-off = 60 U/mL, Advia Centaur XP, Siemens
Search for other papers by Allan Carlé in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Faber in
Google Scholar
PubMed
Search for other papers by Rudi Steffensen in
Google Scholar
PubMed
Search for other papers by Peter Laurberg in
Google Scholar
PubMed
Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Birte Nygaard in
Google Scholar
PubMed
with biochemically restored euthyroidism due to L-T4 substitution and found that the group of patients dissatisfied with their treatment had the same serum TSH, T3, and T4 concentrations as the patients having no complaints. A different co
Search for other papers by Naohiro Araki in
Google Scholar
PubMed
Search for other papers by Mitsuru Iida in
Google Scholar
PubMed
Search for other papers by Nobuyuki Amino in
Google Scholar
PubMed
Search for other papers by Shinji Morita in
Google Scholar
PubMed
Search for other papers by Akane Ide in
Google Scholar
PubMed
Search for other papers by Eijun Nishihara in
Google Scholar
PubMed
Search for other papers by Mitsuru Ito in
Google Scholar
PubMed
Search for other papers by Jun Saito in
Google Scholar
PubMed
Search for other papers by Tetsuo Nishikawa in
Google Scholar
PubMed
Search for other papers by Kiyonori Katsuragi in
Google Scholar
PubMed
Search for other papers by Akira Miyauchi in
Google Scholar
PubMed
; 37 female); 45 with thyrotoxic subacute thyroiditis (mean age 44 years, range 27-79 years; 42 female), 102 with chronic thyroiditis (52 euthyroid; mean age 53 years, range 15-79 years; 48 female); 50 with hypothyroidism (mean age 55 years, range 16
Department of Neurology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Birgitta Johansson in
Google Scholar
PubMed
Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Search for other papers by Mats Holmberg in
Google Scholar
PubMed
Department of Pedagogical, Curricular and Professional Studies, Faculty of Education, University of Gothenburg, Gothenburg, Sweden
Search for other papers by Simon Skau in
Google Scholar
PubMed
Search for other papers by Helge Malmgren in
Google Scholar
PubMed
Wallenberg’s Centre of Molecular and Translational Medicine, Region Västra Götaland, Sweden
Department of Endocrinology, Sahlgrenska University Hospital, Gothenburg, Sweden
Search for other papers by Helena Filipsson Nyström in
Google Scholar
PubMed
Introduction Untreated hyperthyroid patients with Graves’ disease (GD, autoimmune hyperthyroidism) often report fatigue, cognitive problems, and emotional distress. Once the patients are regarded as clinically recovered and euthyroid, the